Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Autoři	SPANJAART AM LJUNGMAN P DE La Camara R TRIDELLO G ORTIZ-MALDONADO V URBANO-ISPIZUA A BARBA P KWON M CABALLERO D SESQUES P BACHY E DI Blasi R THIEBLEMONT C CALKOEN F MUTSAERS P MAERTENS J GIANNONI L NICHOLSON E COLLIN M VAZ CP METAFUNI E MARTINEZ-LOPEZ J DIGNAN FL RIBERA JM NAGLER A FOLBER František SANDERSON R BLOOR A CICERI F KNELANGE N AYUK F KROGER N KERSTEN MJ MIELKE S
Rok publikování	2021
Druh	Článek v odborném periodiku
Časopis / Zdroj	Leukemia
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Doi	http://dx.doi.org/10.1038/s41375-021-01466-0